Facilitated subcutaneous immunoglobulin 10% for CIDP: interim results from a long-term safety and tolerability study

被引：0
|
作者：
Hadden, R. [1 ]
Andersen, H. [2 ]
Bril, V. [3 ]
Basta, I. [4 ]
Rejdak, K. [5 ]
Djordjevic, G. [6 ]
Greco, E. [7 ]
Hasan, S. [7 ]
French, J. [7 ]
Yel, L. [7 ]
Ay, H. [7 ]
机构：
[1] Kings Coll Hosp London, Dept Neurol, London, England
[2] Aarhus Univ, Aarhus, Denmark
[3] Univ Toronto, Univ Hlth Network, Ellen & Martin Prosserman Ctr Neuromuscular Dis, Toronto, ON, Canada
[4] Univ Belgrade, Univ Clin Ctr Serbia, Neurol Clin, Fac Med, Belgrade, Serbia
[5] Med Univ Lublin, Dept Neurol, Lublin, Poland
[6] Univ Clin Ctr Nis, Neurol Clin, Nish, Serbia
[7] Takeda Dev Ctr Amer Inc, Cambridge, MA USA
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2023年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPR-244
引用
收藏
页码：286 / 286
页数：1
相关论文
共 50 条
  • [41] Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Efgartigimod PH20 in Patients with Generalized Myasthenia Gravis: Interim Results of the ADAPT-SC plus Study
    Ritt, Elissa
    Howard, James F., Jr.
    Li, George
    Vu, Tuan
    Korobko, Denis
    Smilowski, Marek
    Liu, Li
    Steeland, Sophie
    Noukens, Jan
    Van Hoorick, Benjamin
    Podhorna, Jana
    Li, Yuebing
    Utsugisawa, Kimiaki
    Sacca, Francesco
    Wiendl, Heinz
    De Bleecker, Jan L.
    Mantegazza, Renato
    ANNALS OF NEUROLOGY, 2023, 94 : S244 - S245
  • [42] Real-World Safety and Tolerability of Facilitated Subcutaneous Immunoglobulin in Pediatric Patients with Primary Immunodeficiency Diseases: Interim Analysis from a Post-authorization Study in Europe
    Ciznar, Peter
    Roderick, Marion
    Schneiderova, Helena
    Jesenak, Milos
    Krivan, Gergely
    Brodszki, Nicholas
    Jolles, Stephen
    Fielhauer, Katharina
    Saeed-Khawaja, Shumyla
    McCoy, Barbara
    Yel, Leman
    JOURNAL OF CLINICAL IMMUNOLOGY, 2021, 41 (SUPPL 1) : S97 - S98
  • [43] Safety and tolerability of brexpiprazole in adults with schizophrenia: results of an openlabel, long-term study
    Weiss, C.
    Forbes, A.
    Hobart, M.
    Ouyang, J.
    Pfister, S.
    Eriksson, H.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S953 - S954
  • [44] Subcutaneous immunoglobulin in CIDP and MMN: a short-term nationwide study
    Dario Cocito
    Aristide Merola
    Erdita Peci
    Anna Mazzeo
    Raffaella Fazio
    Ada Francia
    Paola Valentino
    Rocco Liguori
    Massimiliano Filosto
    Gabriele Siciliano
    Angelo Maurizio Clerici
    Stefania Lelli
    Girolama Alessandra Marfia
    Giovanni Antonini
    Ilaria Cecconi
    Eduardo Nobile-Orazio
    Leonardo Lopiano
    Journal of Neurology, 2014, 261 : 2159 - 2164
  • [45] Switch from intravenous to subcutaneous immunoglobulin in CIDP and MMN: improved tolerability and patient satisfaction
    Hadden, Robert D. M.
    Marreno, Fabrizio
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2015, 8 (01) : 14 - 19
  • [46] LONG-TERM SAFETY OF LANADELUMAB IN HEREDITARY ANGIOEDEMA (HAE): INTERIM RESULTS FROM THE HELP OLE STUDY
    Johnston, D.
    Banerji, A.
    Nurse, C.
    Lu, P.
    Aygoren-Pursun, E.
    Kiani-Alikhan, S.
    Soteres, D.
    Lugar, P.
    Zuraw, B.
    Lockey, R.
    Schwartz, L.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (05) : S30 - S30
  • [47] Subcutaneous immunoglobulin in CIDP and MMN: a short-term nationwide study
    Cocito, Dario
    Merola, Aristide
    Peci, Erdita
    Mazzeo, Anna
    Fazio, Raffaella
    Francia, Ada
    Valentino, Paola
    Liguori, Rocco
    Filosto, Massimiliano
    Siciliano, Gabriele
    Clerici, Angelo Maurizio
    Lelli, Stefania
    Marfia, Girolama Alessandra
    Antonini, Giovanni
    Cecconi, Ilaria
    Nobile-Orazio, Eduardo
    Lopiano, Leonardo
    JOURNAL OF NEUROLOGY, 2014, 261 (11) : 2159 - 2164
  • [48] Interim Analysis of the Global Postauthorization Safety Study of Facilitated Subcutaneous Immunoglobulin Treatment in Patients With Primary Immunodeficiency Diseases
    Rubinstein, Arye
    Patel, Niraj
    Wedner, H. James
    Wasserman, Richard L.
    Gupta, Sudhir
    Fielhauer, Katharina
    Chavan, Shailesh
    Yel, Leman
    JOURNAL OF CLINICAL IMMUNOLOGY, 2020, 40 (SUPPL 1) : S74 - S74
  • [49] Long-term safety and tolerability of apremilast in patients with moderate to severe psoriasis: Results from the LIBERATE study
    Crowley, Jeffrey
    Langley, Richard
    Zhang, Zuoshun
    Goncalves, Joana
    Paris, Maria
    Reich, Kristian
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB259 - AB259
  • [50] SAFETY, TOLERABILITY, AND EFFICACY OF LONG-TERM ADMINISTRATION OF AMG 145: PRELIMINARY RESULTS FROM THE OSLER STUDY
    Koren, M. J.
    Giugliano, R. P.
    Raal, F.
    Sullivan, D.
    Bolognese, M.
    Langslet, G.
    Civeira, F.
    Scott, R.
    Somaratne, R.
    Nelson, P.
    Liu, T.
    Xu, F.
    Wasserman, S. M.
    Sabatine, M. S.
    CANADIAN JOURNAL OF CARDIOLOGY, 2013, 29 (10) : S332 - S332
12345